Drug
Mt200605
Mt200605: highest development phase Phase 2, developed by Shaanxi Micot Pharmaceutical Technology Co., Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| MT200605 NCT07205328 | Phase 2 | Acute Ischemic Stroke |
Latest
No recent events.
Follow Mt200605 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.